Designed to serve as consistent references in a concise manner, the IMF’s Tip Cards cover key topics, including treatment and care issues of interest to patients and caregivers. All of the Tip cards below can be downloaded, free of charge.
April 29, 2021
Abecma® (idecabtagene vicleucel, “ide-cel”) is the first-in-class B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell…
March 18, 2022
This Tip Card covers the importance of treatment adherence.
February 01, 2019
When confronted with a diagnosis of multiple myeloma, consult with a myeloma specialist about treatment options.
February 16, 2022
Bispecific antibody therapies are a combination of two immunotherapy approaches in one drug. Bispecifics are comprised of two monoclonal antibodies…
August 18, 2022
Blenrep (belantamab mafodotin-blmf) is an antibody-drug conjugate (ADC), the first in a new class of treatments for myeloma. Blenrep is the…
We Thank Our Sponsors:
BMS, GSK, Janssen, Karyopharm Therapeutics, Legend Biotech, Sanofi, and Takeda Oncology